238 related articles for article (PubMed ID: 31034983)
21. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics.
Wang J; Galgoci A; Kodali S; Herath KB; Jayasuriya H; Dorso K; Vicente F; González A; Cully D; Bramhill D; Singh S
J Biol Chem; 2003 Nov; 278(45):44424-8. PubMed ID: 12952956
[TBL] [Abstract][Full Text] [Related]
22. Synthetic inhibitors of bacterial cell division targeting the GTP-binding site of FtsZ.
Ruiz-Avila LB; Huecas S; Artola M; Vergoñós A; Ramírez-Aportela E; Cercenado E; Barasoain I; Vázquez-Villa H; Martín-Fontecha M; Chacón P; López-Rodríguez ML; Andreu JM
ACS Chem Biol; 2013 Sep; 8(9):2072-83. PubMed ID: 23855511
[TBL] [Abstract][Full Text] [Related]
23. Mutation of G51 in SepF impairs FtsZ assembly promoting ability of SepF and retards the division of
Bhattacharya D; Sinha K; Panda D
Biochem J; 2018 Aug; 475(15):2473-2489. PubMed ID: 30006469
[TBL] [Abstract][Full Text] [Related]
24. Plumbagin inhibits cytokinesis in Bacillus subtilis by inhibiting FtsZ assembly--a mechanistic study of its antibacterial activity.
Bhattacharya A; Jindal B; Singh P; Datta A; Panda D
FEBS J; 2013 Sep; 280(18):4585-99. PubMed ID: 23841620
[TBL] [Abstract][Full Text] [Related]
25. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
26. Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening.
Kinjo T; Koseki Y; Kobayashi M; Yamada A; Morita K; Yamaguchi K; Tsurusawa R; Gulten G; Komatsu H; Sakamoto H; Sacchettini JC; Kitamura M; Aoki S
J Chem Inf Model; 2013 May; 53(5):1200-12. PubMed ID: 23600706
[TBL] [Abstract][Full Text] [Related]
27. GTPase activity of mycobacterial FtsZ is impaired due to its transphosphorylation by the eukaryotic-type Ser/Thr kinase, PknA.
Thakur M; Chakraborti PK
J Biol Chem; 2006 Dec; 281(52):40107-13. PubMed ID: 17068335
[TBL] [Abstract][Full Text] [Related]
28. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs.
Beuria TK; Singh P; Surolia A; Panda D
Biochem J; 2009 Sep; 423(1):61-9. PubMed ID: 19583568
[TBL] [Abstract][Full Text] [Related]
29. Essential protein SepF of mycobacteria interacts with FtsZ and MurG to regulate cell growth and division.
Gupta S; Banerjee SK; Chatterjee A; Sharma AK; Kundu M; Basu J
Microbiology (Reading); 2015 Aug; 161(8):1627-1638. PubMed ID: 25971440
[TBL] [Abstract][Full Text] [Related]
30. Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
Mathew B; Hobrath JV; Ross L; Connelly MC; Lofton H; Rajagopalan M; Guy RK; Reynolds RC
PLoS One; 2016; 11(10):e0164100. PubMed ID: 27768711
[TBL] [Abstract][Full Text] [Related]
31. Piperine production by endophytic fungus Periconia sp. isolated from Piper longum L.
Verma VC; Lobkovsky E; Gange AC; Singh SK; Prakash S
J Antibiot (Tokyo); 2011 Jun; 64(6):427-31. PubMed ID: 21505472
[TBL] [Abstract][Full Text] [Related]
32. Conformational Flexibility of A Highly Conserved Helix Controls Cryptic Pocket Formation in FtsZ.
Alnami A; Norton RS; Pena HP; Haider S; Kozielski F
J Mol Biol; 2021 Jul; 433(15):167061. PubMed ID: 34023403
[TBL] [Abstract][Full Text] [Related]
33. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
34. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
Sharma S; Kumar M; Sharma S; Nargotra A; Koul S; Khan IA
J Antimicrob Chemother; 2010 Aug; 65(8):1694-701. PubMed ID: 20525733
[TBL] [Abstract][Full Text] [Related]
35. Identification of agents targeting FtsZ assembly.
Panda D; Bhattacharya D; Gao QH; Oza PM; Lin HY; Hawkins B; Hibbs DE; Groundwater PW
Future Med Chem; 2016 Jun; 8(10):1111-32. PubMed ID: 27284850
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy.
Li Z; Garner AL; Gloeckner C; Janda KD; Carlow CK
PLoS Negl Trop Dis; 2011 Nov; 5(11):e1411. PubMed ID: 22140592
[TBL] [Abstract][Full Text] [Related]
37. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
Cloete R; Kapp E; Joubert J; Christoffels A; Malan SF
PLoS One; 2018; 13(11):e0207605. PubMed ID: 30475855
[TBL] [Abstract][Full Text] [Related]
38. Structure-based virtual screening and biological evaluation of novel inhibitors of mycobacterium Z-ring formation.
Alexey R; Dariya S; Liudmyla I; Lilia V; Valeriy M; Dmytro L; Oleksandr B; Svitlana S; Sergii O; Elijah B; Mariia S; Yaroslav B; Pavel K
J Cell Biochem; 2022 May; 123(5):852-862. PubMed ID: 35297088
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial peptide CRAMP (16-33) stalls bacterial cytokinesis by inhibiting FtsZ assembly.
Ray S; Dhaked HP; Panda D
Biochemistry; 2014 Oct; 53(41):6426-9. PubMed ID: 25294259
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the GTP-binding and synergy loop domains of Mycobacterium tuberculosis ftsZ compromise its function in vitro and in vivo.
Rajagopalan M; Atkinson MA; Lofton H; Chauhan A; Madiraju MV
Biochem Biophys Res Commun; 2005 Jun; 331(4):1171-7. PubMed ID: 15882999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
